Zurampic

Active Ingredient(s): Lesinurad
FDA Approved: * December 22, 2015
Pharm Company: * ARDEA BIOSCIENCES INC
Category: Gout

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zurampic Overview

Lesinurad (brand name Zurampic, /zræmpk/ z-RAM-pik) is a urate transporter inhibitor for treating hyperuricemia associated with gout.[1] It received FDA approval on 22 December 2015.[2][3] The European Commission granted a marketing authorisation valid throughout the European Union on 18 February 2016.[4] Contents 1 Medical uses 2 Contraindications 3 Side effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2...

Read more Zurampic Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lesinurad

Recent Zurampic Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lesinurad
  • Tablet: 200mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zurampic: (2 results)

Sorted by National Drug Code
  • 0310-1475 Zurampic 200 mg Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
  • 70785-011 Zurampic 200 mg Oral Tablet, Film Coated by Ironwood Pharmaceuticals, Inc.

Other drugs which contain Lesinurad or a similar ingredient: (3 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA